Latest stories on ODTX
Odyssey Therapeutics, Inc. (ODTX) Discusses Additional Phase IIa Data for OD-001 in Ulcerative Colitis from UEG Week Presentation Transcript
Seeking Alpha58 · neutralproduct/pr
Odyssey Therapeutics reports OD-001 trial meets primary endpoint
The Fly74 · bullishproduct/pr
Odyssey Therapeutics, Inc. (ODTX) files 8-K
SEC 8-K50 · neutralgeneral
Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026
GlobeNewswire64 · neutralproduct/pr
Odyssey Therapeutics spotlights a 146-patient Phase 2a combo study for OD-001 plus vedolizumab in ulcerative colitis
October 13, 2026
MarketChameleon58 · neutralproduct/pr
Odyssey Therapeutics to Present Design of Phase 2a Study Evaluating OD-001 in Combination with Vedolizumab at ACG 2026
StockTitan56 · neutralproduct/pr
Odyssey Therapeutics to Present Design of Phase 2a Study Evaluating OD-001 in Combination with Vedolizumab at ACG 2026
GlobeNewswire53 · neutralproduct/pr
Odyssey Therapeutics initiated with a Buy at UBS
The Fly63 · neutralanalyst
Raymond James initiates Odyssey Therapeutics stock coverage with outperform rating
Investing.com Analyst Ratings63 · neutralanalyst
Odyssey Therapeutics initiated with an Outperform at Raymond James
The Fly63 · neutralanalyst
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
GlobeNewswire63 · neutralproduct/pr
Odyssey Therapeutics, Inc. (ODTX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
GlobeNewswire56 · neutralgeneral
Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
StockTitan56 · neutralgeneral
Odyssey Therapeutics (ODTX) Banks Two More Years As Trials Multiply
Yahoo Finance56 · neutralproduct/pr
H.C. Wainwright has increased confidence in Odyssey after Beeline data
The Fly63 · neutralanalyst
Odyssey Therapeutics, Inc. (ODTX) files 8-K
SEC 8-K50 · neutralgeneral
H.C. Wainwright initiates Odyssey Therapeutics stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Odyssey Therapeutics initiated with a Buy at H.C. Wainwright
The Fly61 · neutralanalyst
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
StockTitan56 · neutralgeneral
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
StockTitan56 · neutralproduct/pr
Odyssey Therapeutics, Inc. (ODTX) files 8-K
SEC 8-K50 · neutralgeneral